LSDIF — Lucy Scientific Discovery Balance Sheet
0.000.00%
- $0.00m
- -$0.14m
- $0.01m
- 21
- 83
- 33
- 43
Annual balance sheet for Lucy Scientific Discovery, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.05 | 0.246 | 0.053 | 1.67 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.014 | 0.013 | 0.013 | 0.406 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.101 | 2.01 | 1.9 | 3.82 |
Net Property, Plant And Equipment | 0 | 0.844 | 0.844 | 1.79 |
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 0.119 | 5.55 | 4.63 | 8.78 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 3.73 | 4.77 | 5.81 | 2.71 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 4.46 | 11.9 | 9.41 | 4.1 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -4.34 | -6.36 | -4.78 | 4.68 |
Total Liabilities & Shareholders' Equity | 0.119 | 5.55 | 4.63 | 8.78 |
Total Common Shares Outstanding |